Collin Blakely
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping Mutation (NCT05435846) | Collin Blakely | 2022-08-10 |
| Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer (NCT04085315) | Collin Blakely | 2019-11-12 |
Track Collin Blakely automatically
Every clearance here is in the API, with alerts when new ones post.